Skip to main content
Caplight Logo









Mendra, Inc.

Mendra, Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://mendra.com/

Last Round

Series A

Jan 21, 2026

Total Funding Raised

$164M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Mendra, Inc. is a biopharmaceutical company that acquires, develops, and commercializes therapies for rare diseases using artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical AI, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

rare disease therapeuticsbiopharmaceuticaldrug developmentclinical trial enrollmentpatient identificationAI-enabled drug discoverybiotechasset acquisitionhealthcare analyticsCDMOcontract developmentdrug commercializationAI-first biotechorphan drug developmentpharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mendra, Inc. Comparables

Compare Mendra, Inc. with similar companies based on industry and business-model similarity.

Mendra, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Real Chemistry
69%
BridgeBio Pharma, Inc.
67%
Unravel Biosciences
63%

Mendra, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 21, 2026
Series AJan 21, 2026

Key People

Founding team and executive leadership

Lalarukh Haris Shaikh

Co-founder & CTO

Founding Team

Mendra, Inc. Investors

Notable investors and investment history

Mendra, Inc. investors
InvestorRounds
OrbiMedSeries A
5AM VenturesSeries A
Lux CapitalSeries A
Wing Venture CapitalSeries A
8VCSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Grew 43% QoQ, from 7 to 10 employees.

  • May 16, 2026

    Grew 80% QoQ, from 5 to 9 employees.

Mendra, Inc. Filings

Explore SEC and related filing metadata, where available.

Mendra, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mendra, Inc.'s valuation, stock price, and market status.

Is Mendra, Inc. a public or private company?

Mendra, Inc. is a private company.

What is the current stock price of Mendra, Inc.?

Mendra, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Mendra, Inc. worth (valuation)?

Valuation information for Mendra, Inc. is not publicly available.

Can I buy Mendra, Inc. stock?

Mendra, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Mendra, Inc.'s last funding round?

Mendra, Inc.'s most recent funding round was Series A on January 22, 2026.

Who are the main investors in Mendra, Inc.?

Key investors in Mendra, Inc. include OrbiMed, 5AM Ventures, 8VC.

Will Mendra, Inc. IPO soon?

No public IPO plans have been announced for Mendra, Inc..

How can I track Mendra, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mendra, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range7
Year Founded2026
Last FundingJan 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?